Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 18, Number 1—January 2012
Dispatch

Emergence of Blastoschizomyces capitatus Yeast Infections, Central Europe

Tanja BirrenbachComments to Author , Sonja Bertschy, Franziska Aebersold, Nicolas J. Mueller, Yvonne Achermann, Konrad Muehlethaler, and Stefan Zimmerli
Author affiliations: University Hospital Bern, Bern, Switzerland (T. Birrenbach, S. Zimmerli); Kantonsspital Luzern, Lucern, Switzerland (S. Bertschy, F. Aebersold); University Hospital Zurich, Zurich, Switzerland (N.J. Mueller, Y. Achermann); University of Bern, Bern (K. Muehlethaler, S. Zimmerli)

Main Article

Table 2

In vitro antifungal susceptibility profile according to microtiter broth dilution for patients with Blastoschizomyces capitatus yeast infections, Switzerland, June 2009–June 2010*

Patient no. MIC, μg/mL
AMB 5-FC FLC ITC VRC POS CAS
1 0.5 0.03 2 0.06 0.016 0.25 4
2 0.5 0.03 8 0.12 0.06 0.25 4
3 0.5 (3)† 0.06 4 0.06 0.06 0.25 8
4 0.5 16 1 0.032 0.032 0.064 4
5 0.5 0.12 16 0.25 0.25 0.5 >16

*AMB, deoxycholate amphotericin B; 5-FC, 5-fluorocytosine; FLC, fluconazole; ITC, itraconazole; VRC, voriconazole; POS, posaconazole; CAS, caspofungin.
†By Etest (bioMérieux, Marcy l’Etoile, France), the isolate had an AMB MIC of 3 μg/mL.

Main Article

References
  1. Malani  AN, Kauffman  CA. Changing epidemiology of rare mould infections: implications for therapy. Drugs. 2007;67:1803–12. DOIPubMedGoogle Scholar
  2. Roden  MM, Zaoutis  TE, Buchanan  WL, Knudsen  TA, Sarkisova  TA, Schaufele  RL, Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41:634–53. DOIPubMedGoogle Scholar
  3. Imhof  A, Balajee  SA, Fredricks  DN, Englund  JA, Marr  KA. Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole. Clin Infect Dis. 2004;39:743–6. DOIPubMedGoogle Scholar
  4. Casadevall  A. Fungal virulence, vertebrate endothermy, and dinosaur extinction: is there a connection? Fungal Genet Biol. 2005;42:98–106. DOIPubMedGoogle Scholar
  5. Robert  VA, Casadevall  A. Vertebrate endothermy restricts most fungi as potential pathogens. J Infect Dis. 2009;200:1623–6. DOIPubMedGoogle Scholar
  6. Bouza  E, Munoz  P. Invasive infections caused by Blastoschizomyces capitatus and Scedosporium spp. Clin Microbiol Infect. 2004;10(Suppl 1):76–85. DOIPubMedGoogle Scholar
  7. Girmenia  C, Pagano  L, Martino  B, D'Antonio  D, Fanci  R, Specchia  G, Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literature. J Clin Microbiol. 2005;43:1818–28. DOIPubMedGoogle Scholar
  8. Martino  R, Salavert  M, Parody  R, Tomas  JF, de la Camara  R, Vazquez  L, Blastoschizomyces capitatus infection in patients with leukemia: report of 26 cases. Clin Infect Dis. 2004;38:335–41. DOIPubMedGoogle Scholar
  9. Martino  P, Venditti  M, Micozzi  A, Morace  G, Polonelli  L, Mantovani  MP, Blastoschizomyces capitatus: an emerging cause of invasive fungal disease in leukemia patients. Rev Infect Dis. 1990;12:570–82. DOIPubMedGoogle Scholar
  10. Pfaller  MA, Diekema  DJ, Gibbs  DL, Newell  VA, Meis  JF, Gould  IM, Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing. J Clin Microbiol. 2007;45:1735–45. DOIPubMedGoogle Scholar
  11. Pfaller  MA, Diekema  DJ, Merz  WG. Infections caused by non-Candida, non-cryptococcal yeasts. In: Anaissie EJ, McGinnis MR, Pfaller MA, editors. Clinical Mycology. 2nd ed. New York: Churchill Livingstone Elsevier; 2009. p. 261.
  12. Oelz  O, Schaffner  A, Frick  P, Schaer  G. Trichosporon capitatum: thrush-like oral infection, local invasion, fungaemia and metastatic abscess formation in a leukaemic patient. J Infect. 1983;6:183–5. DOIPubMedGoogle Scholar
  13. Freydiere  AM, Guinet  R, Boiron  P. Yeast identification in the clinical microbiology laboratory: phenotypical methods. Med Mycol. 2001;39:9–33.PubMedGoogle Scholar
  14. Bundesamt für Meteorologie und Klimatologie. Klimatrends Schweiz [cited 2011 Jul 7]. http://www.meteoswiss.admin.ch/web/de/klima/klima_heute/trends_schweiz.html
  15. Garcia-Solache  MA, Casadevall  A. Global warming will bring new fungal diseases for mammals. MBio. 2010;1; pii:e00061–10.

Main Article

Page created: December 19, 2011
Page updated: December 19, 2011
Page reviewed: December 19, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external